BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10199687)

  • 1. Factors affecting bargaining outcomes between pharmacies and insurers.
    Brooks JM; Doucette W; Sorofman B
    Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retail pharmacy market structure and insurer-independent pharmacy bargaining in the Medicare Part D era.
    Xie Y; Brooks JM; Urmie JM; Doucette WR
    Adv Health Econ Health Serv Res; 2010; 22():295-316. PubMed ID: 20575238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does bargaining affect Medicare prescription drug plan reimbursements to independent pharmacies?
    Tang Y; Xie Y; Urmie JM; Doucette WR
    J Am Pharm Assoc (2003); 2011; 51(6):738-45. PubMed ID: 22068196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third party bargaining and contract terms: a link over time?
    Brooks JM; Doucette WR; Sorofman BA
    J Am Pharm Assoc (Wash); 2002; 42(3):420-7. PubMed ID: 12030628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do health insurer market concentration and bargaining power with hospitals affect health insurance premiums?
    Trish EE; Herring BJ
    J Health Econ; 2015 Jul; 42():104-14. PubMed ID: 25910690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
    Erickson SR; Workman P
    J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and determinants of retail prescription drug costs.
    Teasdale B; Nguyen A; van Meijgaard J; Schulman KA
    Health Serv Res; 2022 Jun; 57(3):548-556. PubMed ID: 35211965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insurer Market Power Lowers Prices In Numerous Concentrated Provider Markets.
    Scheffler RM; Arnold DR
    Health Aff (Millwood); 2017 Sep; 36(9):1539-1546. PubMed ID: 28874479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.
    Roberts ET; Chernew ME; McWilliams JM
    Health Aff (Millwood); 2017 Jan; 36(1):141-148. PubMed ID: 28069857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retail pharmacy market structure and performance.
    Brooks JM; Doucette WR; Wan S; Klepser DG
    Inquiry; 2008; 45(1):75-88. PubMed ID: 18524293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
    Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
    JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completeness of retail pharmacy claims data: implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients.
    Polinski JM; Schneeweiss S; Levin R; Shrank WH
    Clin Ther; 2009 Sep; 31(9):2048-59. PubMed ID: 19843494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.
    Luo J; Kulldorff M; Sarpatwari A; Pawar A; Kesselheim AS
    Ann Intern Med; 2019 Nov; 171(9):605-611. PubMed ID: 31569218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negotiating with third party payers: one community pharmacy's experience.
    Fridy K; DeHart RM; Monk-Tutor MR
    J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse pharmaceutical payment incentives and providers' behaviour: the emergence of GP-owned gateway pharmacies in Taiwan.
    Lee YC; Huang KH; Huang YT
    Health Policy Plan; 2007 Nov; 22(6):427-35. PubMed ID: 17901065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-insurer bargaining: an empirical investigation of appendectomy pricing.
    Brooks JM; Dor A; Wong HS
    J Health Econ; 1997 Aug; 16(4):417-34. PubMed ID: 10169099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping pharmacy deserts and determining accessibility to community pharmacy services for elderly enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P; Peterson A
    PLoS One; 2018; 13(6):e0198173. PubMed ID: 29864159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.